Diagnostic Accuracy of Procalcitonin for Predicting Blood Culture Results in Patients with Suspected Bloodstream Infection

Medicine (United States)

Volumn 94, Issue 44, 2015, Pages e1774-

  Oussalah, Abderrahim ^a,b   Ferrand, Janina ^a,c   Filhine Tresarrieu, Pierre ^a   Aissa, Nejla ^a,c   Aimone Gastin, Isabelle ^a,b   Namour, Fares ^a,b   Garcia, Matthieu ^a   Lozniewski, Alain ^a,c   Gueánt, Jean Louis ^a,b  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c UNIVERSITÉ DE LORRAINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROCALCITONIN; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

ACINETOBACTER; ADOLESCENT; ADULT; AGED; ANAEROBIC BACTERIUM; ARTICLE; BACTEROIDES; BLOOD BIOCHEMISTRY; BLOOD CULTURE; BLOODSTREAM INFECTION; CHILD; CITROBACTER; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENTEROBACTERIACEAE; ENTEROCOCCUS; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; INFANT; KLEBSIELLA; MAJOR CLINICAL STUDY; MYCOSIS; NONHUMAN; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PSEUDOMONAS; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; BACTEREMIA; BACTERIUM; BLOOD; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; FEMALE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; REPRODUCIBILITY;

BACTEREMIA; BACTERIA; BIOMARKERS; CALCITONIN; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; REPRODUCIBILITY OF RESULTS;

EID: 84960992846     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001774     Document Type: Article

References (45)

1. Becker KL, Snider R, Nylen ES. Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. Br J Pharmacol. 2010;159:253-264.
2. Russell JA. Management of sepsis. N Engl J Med. 2006;355:1699-1713.
3. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840-851.
4. Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341:515-518.
5. Tang BM, Eslick GD, Craig JC, et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and metaanalysis. Lancet Infect Dis. 2007;7:210-217.
6. Wacker C, Prkno A, Brunkhorst FM, et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13:426-435.
7. Vouloumanou EK, Plessa E, Karageorgopoulos DE, et al. Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis. Intensive Care Med. 2011;37:747-762.
8. Schuetz P, Briel M, Christ-Crain M, et al. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis. Clin Infect Dis. 2012;55:651-662.
9. Nobre V, Harbarth S, Graf JD, et al. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med. 2008;177:498-505.
10. Bouadma L, Luyt CE, Tubach F, et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 2010;375:463-474.
11. Schuetz P, Chiappa V, Briel M, et al. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med. 2011;171:1322-1331.
12. Bates DW, Cook EF, Goldman L, et al. Predicting bacteremia in hospitalized patients. A prospectively validated model. Ann Intern Med. 1990;113:495-500.
13. Bates DW, Sands K, Miller E, et al. Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group. J Infect Dis. 1997;176:1538-1551.
14. Chirouze C, Schuhmacher H, Rabaud C, et al. Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever. Clin Infect Dis. 2002;35:156-161.
15. Tokuda Y, Miyasato H, Stein GH. A simple prediction algorithm for bacteraemia in patients with acute febrile illness. QJM. 2005;98:813-820.
16. Shapiro NI, Wolfe RE, Wright SB, et al. Who needs a blood culture A prospectively derived and validated prediction rule. J Emerg Med. 2008;35:255-264.
17. Muller F, Christ-Crain M, Bregenzer T, et al. Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial. Chest. 2010;138:121-129.
18. van Nieuwkoop C, Bonten TN, van't Wout JW, et al. Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. Crit Care. 2010;14:R206.
19. Albrich WC, Mueller B. Predicting bacteremia by procalcitonin levels in patients evaluated for sepsis in the emergency department. Expert Rev Anti Infect Ther. 2011;9:653-656.
20. Riedel S, Melendez JH, An AT, et al. Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department. Am J Clin Pathol. 2011;135:182-189.
21. Mencacci A, Leli C, Cardaccia A, et al. Procalcitonin predicts realtime PCR results in blood samples from patients with suspected sepsis. PLoS One. 2012;7:e53279.
22. Jeong S, Park Y, Cho Y, et al. Diagnostic utilities of procalcitonin and C-reactive protein for the prediction of bacteremia determined by blood culture. Clin Chim Acta. 2012;413:1731-1736.
23. Brodska H, Malickova K, Adamkova V, et al. Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis. Clin Exp Med. 2013;13:165-170.
24. Sugimoto K, Adomi S, Koike H, et al. Procalcitonin as an indicator of urosepsis. Res Rep Urol. 2013;5:77-80.
25. Cortegiani A, Russotto V, Montalto F, et al. Procalcitonin as a marker of Candida species detection by blood culture and polymerase chain reaction in septic patients. BMC Anesthesiol. 2014;14:9.
26. Naffaa M, Makhoul BF, Tobia A, et al. Procalcitonin and interleukin 6 for predicting blood culture positivity in sepsis. Am J Emerg Med. 2014;32:448-451.
27. Hattori T, Nishiyama H, Kato H, et al. Clinical value of procalcitonin for patients with suspected bloodstream infection. Am J Clin Pathol. 2014;141:43-51.
28. Arai T, Kumasaka K, Nagata K, et al. Prediction of blood culture results by measuring procalcitonin levels and other inflammatory biomarkers. Am J Emerg Med. 2014;32:330-333.
29. Lee J, Hwang SS, Kim K, et al. Bacteremia prediction model using a common clinical test in patients with community-acquired pneumonia. Am J Emerg Med. 2014;32:700-704.
30. Kruger S, Ewig S, Papassotiriou J, et al. Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ. Respir Res. 2009;10:65.
31. Muller F, Christ-Crain M, Bregenzer T, et al. Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial. Chest. 2010;138:121-129.
32. Charles PE, Ladoire S, Aho S, et al. Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria. BMC Infect Dis. 2008;8:38.
33. Lee CC, Lin WJ, Shih HI, et al. Clinical significance of potential contaminants in blood cultures among patients in a medical center. J Microbiol Immunol Infect. 2007;40:438-444.
34. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837-845.
35. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. Boca Raton, Florida, USA: Chapman & Hall/CRC; 1994.
36. Matwiyoff GN, Prahl JD, Miller RJ, et al. Immune regulation of procalcitonin: a biomarker and mediator of infection. Inflamm Res. 2012;61:401-409.
37. Morgenthaler NG, Struck J, Chancerelle Y, et al. Production of procalcitonin (PCT) in non-thyroidal tissue after LPS injection. Horm Metab Res. 2003;35:290-295.
38. Muller B, White JC, Nylen ES, et al. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab. 2001;86:396-404.
39. Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994;79:1605-1608.
40. Oberhoffer M, Stonans I, Russwurm S, et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med. 1999;134:49-55.
41. Ryu YH, Baik JE, Yang JS, et al. Differential immunostimulatory effects of Gram-positive bacteria due to their lipoteichoic acids. Int Immunopharmacol. 2009;9:127-133.
42. Troillet N, Samore MH, Carmeli Y. Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns. Clin Infect Dis. 1997;25:1094-1098.
43. Gales AC, Jones RN, Forward KR, et al. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis. 2001;32(Suppl 2):S104-S113.
44. Klastersky J. Empirical antifungal therapy. Int J Antimicrob Agents. 2004;23:105-112.
45. Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546-1554.